Intera invests in Galena Pharma

Avance advises the owners of Galena Pharma in the sale of a majority stake in the company to Intera Partners. Galena Pharma is a leading Finnish pharmaceutical company specialized in contract development, manufacturing and packaging with a focus on innovative medical devices and pharmaceuticals. Following the transaction, the current owners will continue holding a significant stake in the company, and the new co-owner will support its growth and internationalization targets.